Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Gross Margin (2023 - 2025)

Bioregenx (BRGX) has 3 years of Gross Margin data on record, last reported at 83.98% in Q3 2025.

  • For Q3 2025, Gross Margin rose 317.0% year-over-year to 83.98%; the TTM value through Sep 2025 reached 78.14%, up 1114.0%, while the annual FY2024 figure was 70.87%, 311.0% up from the prior year.
  • Gross Margin reached 83.98% in Q3 2025 per BRGX's latest filing, up from 79.03% in the prior quarter.
  • Across five years, Gross Margin topped out at 15479.7% in Q3 2023 and bottomed at 55.76% in Q4 2023.
  • Average Gross Margin over 3 years is 1472.81%, with a median of 71.02% recorded in 2023.
  • Peak YoY movement for Gross Margin: crashed -1539889bps in 2024, then skyrocketed 1502bps in 2025.
  • A 3-year view of Gross Margin shows it stood at 55.76% in 2023, then rose by 26bps to 70.09% in 2024, then increased by 20bps to 83.98% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 83.98% in Q3 2025, 79.03% in Q2 2025, and 78.82% in Q1 2025.